Silhouette

HONG YU LI

Synactix Pharmaceuticals, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Pre-IND Study of Pz-1, a dual pan-RET/VEGFR2 inhibitor for the Treatment of RET-driven Disease
Synactix Pharmaceuticals, Inc.
Principal Investigator
HHS 1 $300K 09/01/15 02/29/16